StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSEAMERICAN:NBY – Get Rating) in a research note released on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. NovaBay Pharmaceuticals Stock Performance NYSEAMERICAN NBY opened at $0.68 on Tuesday. The company has a market capitalization of $1.27 million, a price-to-earnings ratio of […]